178 related articles for article (PubMed ID: 14501870)
1. Skeletal reconstruction by vascularized allogenic bone transplantation: effects of statin in rats.
Ohno T; Shigetomi M; Ihara K; Matsunaga T; Hashimoto T; Kawano H; Sugiyama T; Kawai S
Transplantation; 2003 Sep; 76(5):869-71. PubMed ID: 14501870
[TBL] [Abstract][Full Text] [Related]
2. Effects of cerivastatin on vascularized allogenic bone transplantation in rats treated with cyclosporine A.
Ohno T; Shigetomi M; Ihara K; Ikeda K; Tsubone T; Matsunaga T; Sugiyama T; Kawai S
Calcif Tissue Int; 2003 Jan; 72(1):50-6. PubMed ID: 12384812
[TBL] [Abstract][Full Text] [Related]
3. Effects of cessation of immunosuppression on skeleton reconstructed by vascularized bone allograft in rats.
Ikeda K; Shigetomi M; Ihara K; Tsubone T; Hashimoto T; Kawano H; Sugiyama T; Kawai S
J Orthop Res; 2004 Mar; 22(2):388-94. PubMed ID: 15013101
[TBL] [Abstract][Full Text] [Related]
4. Sequential treatment with intermittent low-dose human parathyroid hormone (1-34) and bisphosphonate enhances large-size skeletal reconstruction by vascularized bone transplantation.
Hashimoto T; Shigetomi M; Ohno T; Matsunaga T; Muramatsu K; Tanaka H; Sugiyama T; Taguchi T
Calcif Tissue Int; 2007 Sep; 81(3):232-9. PubMed ID: 17674071
[TBL] [Abstract][Full Text] [Related]
5. Increase in cerivastatin systemic exposure after single and multiple dosing in cyclosporine-treated kidney transplant recipients.
Mück W; Mai I; Fritsche L; Ochmann K; Rohde G; Unger S; Johne A; Bauer S; Budde K; Roots I; Neumayer HH; Kuhlmann J
Clin Pharmacol Ther; 1999 Mar; 65(3):251-61. PubMed ID: 10096257
[TBL] [Abstract][Full Text] [Related]
6. Direct anti-inflammatory mechanisms contribute to attenuation of experimental allograft arteriosclerosis by statins.
Shimizu K; Aikawa M; Takayama K; Libby P; Mitchell RN
Circulation; 2003 Oct; 108(17):2113-20. PubMed ID: 14517172
[TBL] [Abstract][Full Text] [Related]
7. Effects of vitamin D analog, 22-oxa-1,25-dihydroxyvitamin D(3), on bone reconstruction by vascularized bone allograft.
Merida L; Shigetomi M; Ihara K; Tsubone T; Ikeda K; Yamaguchi A; Sugiyama T; Kawai S
Bone; 2002 Feb; 30(2):422-7. PubMed ID: 11856652
[TBL] [Abstract][Full Text] [Related]
8. Cerivastatin modulates plasma paraoxonase/arylesterase activity and oxidant-antioxidant balance in the rat.
Bełtowski J; Wójcicka G; Mydlarczyk M; Jamroz A
Pol J Pharmacol; 2002; 54(2):143-50. PubMed ID: 12139111
[TBL] [Abstract][Full Text] [Related]
9. Stimulatory effects of statins on bone marrow-derived mesenchymal stem cells. Study of a new therapeutic agent for fracture.
Sonobe M; Hattori K; Tomita N; Yoshikawa T; Aoki H; Takakura Y; Suguro T
Biomed Mater Eng; 2005; 15(4):261-7. PubMed ID: 16010034
[TBL] [Abstract][Full Text] [Related]
10. Site-specific effects of cerivastatin on bone in male Sprague-Dawley rats.
Banu J; Kalu DN
Bone; 2004 Mar; 34(3):432-42. PubMed ID: 15003791
[TBL] [Abstract][Full Text] [Related]
11. Local application of statin promotes bone repair through the suppression of osteoclasts and the enhancement of osteoblasts at bone-healing sites in rats.
Ayukawa Y; Yasukawa E; Moriyama Y; Ogino Y; Wada H; Atsuta I; Koyano K
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Mar; 107(3):336-42. PubMed ID: 18801677
[TBL] [Abstract][Full Text] [Related]
12. A comparison between the effects of hydrophobic and hydrophilic statins on osteoclast function in vitro and ovariectomy-induced bone loss in vivo.
Hughes A; Rogers MJ; Idris AI; Crockett JC
Calcif Tissue Int; 2007 Nov; 81(5):403-13. PubMed ID: 17982704
[TBL] [Abstract][Full Text] [Related]
13. Topical application of statin affects bone healing around implants.
Moriyama Y; Ayukawa Y; Ogino Y; Atsuta I; Koyano K
Clin Oral Implants Res; 2008 Jun; 19(6):600-5. PubMed ID: 18422989
[TBL] [Abstract][Full Text] [Related]
14. Detection of chimerism following vascularized bone allotransplantation by polymerase chain reaction using a Y-chromosome specific primer.
Muramatsu K; Valenzuela RG; Bishop AT
J Orthop Res; 2003 Nov; 21(6):1056-62. PubMed ID: 14554219
[TBL] [Abstract][Full Text] [Related]
15. Hypertrophy of vascularized bone isograft in rats treated with cyclosporine A.
Tsubone T; Shigetomi M; Ihara K; Ikeda K; Merida L; Ohno T; Sugiyama T; Kawai S
Calcif Tissue Int; 2003 Oct; 73(4):393-9. PubMed ID: 14523601
[TBL] [Abstract][Full Text] [Related]
16. Statins induce immunosuppressive effect on heterotopic limb allografts in rat through inhibiting T cell activation and proliferation.
Nie C; Yang D; Liu G; Dong D; Ma Z; Fu H; Zhao Z; Sun Z
Eur J Pharmacol; 2009 Jan; 602(1):168-75. PubMed ID: 19041862
[TBL] [Abstract][Full Text] [Related]
17. Statins and osteoporosis: new role for old drugs.
Jadhav SB; Jain GK
J Pharm Pharmacol; 2006 Jan; 58(1):3-18. PubMed ID: 16393459
[TBL] [Abstract][Full Text] [Related]
18. Vertical bone augmentation with fluvastatin in an injectable delivery system: a rat study.
Jinno Y; Ayukawa Y; Ogino Y; Atsuta I; Tsukiyama Y; Koyano K
Clin Oral Implants Res; 2009 Aug; 20(8):756-60. PubMed ID: 19302395
[TBL] [Abstract][Full Text] [Related]
19. Statin-induced osteogenesis uses in orthodontics: a scientific review.
Wong RW; Rabie AB
World J Orthod; 2006; 7(1):35-40. PubMed ID: 16548304
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of a squalene synthase inhibitor, lapaquistat acetate (TAK-475), on statin-induced myotoxicity in guinea pigs.
Nishimoto T; Ishikawa E; Anayama H; Hamajyo H; Nagai H; Hirakata M; Tozawa R
Toxicol Appl Pharmacol; 2007 Aug; 223(1):39-45. PubMed ID: 17599378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
